ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,101.24
-0.29%
US Tech 100
21,156.80
-0.70%
Dow Jones
44,424.25
-0.32%
Brent Oil
77.625
0.00%
Bitcoin
104,956.20
0.10%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Jenoptik AG (JEN) Quote

Jenoptik AG

Jenoptik AG (JEN)

Jensen group
22.18
0.38
(1.74%)
Closed January 25 4:00PM
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
22.18
Bid
21.98
Ask
22.36
Volume
56,810
21.92 Day's Range 22.52
20.24 52 Week Range 31.10
Market Cap
1.27B
Previous Close
21.80
Open
21.92
Last Trade
90
@
22.36
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
39,343
Shares Outstanding
57,238,115
Dividend Yield
-
PE Ratio
19.04
Earnings Per Share (EPS)
1.27
Revenue
1.07B
Net Profit
72.47M

About Jenoptik AG

Sector
Electronic Components, Nec
Industry
Technology Diversified
Website
www.jenoptik.com
Headquarters
Jena, Deu
Founded
1990
Jenoptik AG is listed in the Electronic Components sector of the Tradegate (DE) with ticker JEN. The last closing price for Jenoptik was 21.80 €. Over the last year, Jenoptik shares have traded in a share price range of 20.24 € to 31.10 €.

Jenoptik currently has 57,238,115 shares outstanding. The market capitalization of Jenoptik is 1.25 € billion. Jenoptik has a price to earnings ratio (PE ratio) of 19.04.

Ask ADVFN Intelligence (AI)

JEN Latest News

More News

Jennifer Convertibles Reports First Quarter Results

- Revenue from continuing operations decreased 12.4% for quarter - Comparable store sales decreased by 12.8% for quarter - Loss from continuing operations ($6,852,000) versus ($1,815,000) for...

January 12 2010
PR Newswire (US)

Jennifer Convertibles Receives a Letter from Amex

WOODBURY, N.Y., Jan. 12 /PRNewswire-FirstCall/ -- Jennifer Convertibles, Inc. (NYSE Amex: JEN) announced today that it has received a notice from the NYSE Amex indicating that the Company is not...

January 12 2010
PR Newswire (US)

Jennifer Convertibles To Open Two Additional Ashley Furniture HomeStores

- Expected To Open In October WOODBURY, N.Y., Aug. 31 /PRNewswire-FirstCall/ -- Jennifer Convertibles, Inc. (NYSE Amex: JEN) announced today that it has signed leases to open two additional...

August 31 2009
PR Newswire (US)

Jennifer Convertibles Reports Third Quarter Results

- Revenue from continuing operations decreased 21.9% for quarter, 20.2% year-to-date - Comparable store sales decreased by 26.5% for quarter, 23.9% year-to-date - Loss from continuing operations...

July 14 2009
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.241.0938924339121.9422.5221.563029522.1935632DE
4-0.04-0.180018001822.2223.3621.0799992416222.23633829DE
120.542.4953789279121.6423.3820.2399993934321.82087753DE
26-4.54-16.991017964126.7229.1820.2399993040423.42252183DE
52-5.34-19.404069767427.5231.120.2399992279824.9594695DE
156-10.02-31.118012422432.233.7818.446269126.85455131DE
260-1.84-7.6602830974224.0237.812.999902525.68505865DE

JEN - Frequently Asked Questions (FAQ)

What is the current Jenoptik share price?
The current share price of Jenoptik is 22.18 €
How many Jenoptik shares are in issue?
Jenoptik has 57,238,115 shares in issue
What is the market cap of Jenoptik?
The market capitalisation of Jenoptik is EUR 1.25B
What is the 1 year trading range for Jenoptik share price?
Jenoptik has traded in the range of 20.24 € to 31.10 € during the past year
What is the PE ratio of Jenoptik?
The price to earnings ratio of Jenoptik is 19.04
What is the cash to sales ratio of Jenoptik?
The cash to sales ratio of Jenoptik is 1.29
What is the reporting currency for Jenoptik?
Jenoptik reports financial results in EUR
What is the latest annual turnover for Jenoptik?
The latest annual turnover of Jenoptik is EUR 1.07B
What is the latest annual profit for Jenoptik?
The latest annual profit of Jenoptik is EUR 72.47M
What is the registered address of Jenoptik?
The registered address for Jenoptik is CARL-ZEISS-STRASSE 1, JENA, 07739
What is the Jenoptik website address?
The website address for Jenoptik is www.jenoptik.com
Which industry sector does Jenoptik operate in?
Jenoptik operates in the TECHNOLOGY DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LL3PanGenomic Health Inc
0.2999 €
(67.26%)
2.89k
VAR1Varta AG
1.00 €
(37.93%)
3.62M
FP9Five Point Holdings LLC
5.35 €
(36.48%)
20
UD9Mason Resources Inc
0.0616 €
(36.28%)
28k
8CTCannabix Technologies Inc
0.32 €
(33.33%)
250
E3TMetavista 3D Inc
1.49 €
(-50.99%)
5.26M
E3O1Nexoptic Technology Corp
0.008 €
(-48.39%)
34.02k
POTAPortofino Resources Inc
0.0032 €
(-38.46%)
150k
G12Global Atomic Corp
0.425 €
(-31.95%)
729.18k
1UR1Bee Vectoring Technologies International Inc
0.0035 €
(-30.00%)
139.6k
PF8European Lithium Limited
0.0348 €
(-3.33%)
9.79M
E3TMetavista 3D Inc
1.49 €
(-50.99%)
5.26M
D7GNel ASA
0.1932 €
(0.99%)
4.13M
0QJHexagon Purus ASA
0.2725 €
(-22.59%)
3.99M
VAR1Varta AG
1.00 €
(37.93%)
3.62M

Discussion

View Full Feed
oldmystic oldmystic 3 minutes ago
I think it is very cool and like it, just not convinced of the value. In corporate life we spent a fair amount of effort on charting software and did extensive studies on TA to determine how much Alfa if any it can provide. The results were not overwhelming, which of course doesn't they can't be for
AVXL
TAB78 TAB78 3 minutes ago
I have this a few times, I take it mean company wants us to know what the AS & OS is

I called OTC once and asked about why its updated daily on some, they said it depends on the arrangement between the company and their TA

Since the TA is the one that reports it to OTC
GRLF
Zorax Zorax 3 minutes ago
We were already dealing with the highest assault of bird flu ever which was already raising prices.

And with rfk in the health spot, he'll not allow vaccines or studies and wait 5 years for everyone to get sick and die from bird flu because of his belief of a defunct and debunked deca
k9narc k9narc 3 minutes ago
I prefer my kale

With a silent K
CanItBThisEZ2Make CanItBThisEZ2Make 4 minutes ago
Thank You, Very Much, That's a straight up $0.43 per share by rough calculations IMO - NFA!

GO $AZRH
AZRH
Invest-in-America Invest-in-America 4 minutes ago
TVGN: Is glorious Microsoft really proactively 'collaborating' with tiny TVGN ; or, is TVGN merely EXPLOITING Microsoft's already-existing AI services & products??? (Be very careful when a little-known company suddenly publishes so-called ' NEWS ' with terms like ' partnering with', or ' tea
TVGN
capgain capgain 4 minutes ago
Tele's and Lucinda, how can you go wrong? :)
KILLAZILLA KILLAZILLA 5 minutes ago
F- CREDIT RATING AND NO POSITIVE INCOME ARE 2 OTHERS....

SHOULD I LIST MORE???

MAMALUKE!!!
WDLF
declaes declaes 5 minutes ago
25,000,000 revenues in 2025!!!

style="font-size: 16px"Based on the prior year revenues in both Kentucky and West Palm Beach, Florida and the addition of the new beds in Boca Raton, Florida, the revenue target for all facilities in the Company for all of 2025 is $25,000,000.00.
GRST
wiwineguy wiwineguy 5 minutes ago
Looks great Mr Chen!  Thank you
TGLO
double_m double_m 6 minutes ago
Real funny when the dreamers show up on this board with posts showing optimism for $MULN. These guys refuse to believe any warnings about this company and its 💩CEO. Most of us have been dealing with Mullen for as much as 3 years and have lost varying amounts of money to the blatant lies and
MULN
ThunderousSeer8 ThunderousSeer8 6 minutes ago
It is tiring even for me seeing him exhausting himself in desperation
RDAR
justhefax justhefax 10 minutes ago
i share the desire for success as i do have a significant stake.
Apart from Schwab i don't see any visible sign of the name change. If any see other places good to know.

I dont see the work you refer to apart from releases going back to spring ( and Schwab). The name change was
KGKG
IhidfromtheX IhidfromtheX 10 minutes ago
Time diagnosed until the average life span for an illness IMO is a great marker...The longer the better...
AVXL
zab zab 11 minutes ago
I have noticed that also, did you see this article.

https://www.seattletimes.com/nation-world/nation/more-dei-fallout-air-force-scraps-course-that-used-videos-of-tuskegee-airmen-and-female-wwii-pilots/

https://www.detroitnews.com/story/news/politics/2025/01/25/air-force
exwannabe exwannabe 12 minutes ago
I think TVO gave end of February as a grace period for some time. Unlike many, he’s willing to say if it goes beyond that, his concern level would increase. Right now, he’s still expecting January (with February as the final grace period). IMO. I pretty much echo his sentiment, based upon his and ly
NWBO
Johnniegalan Johnniegalan 12 minutes ago
JR….tell that to the folks with special insight who have fueled a nearly 50% increase in the price of the stock in the last 3 weeks or so..
AMRN
boi568 boi568 14 minutes ago
If dramatic brain preservation is not a validated biomarker for AD because no other effective drug has achieved the most obviously desirable physical result for this disease, then the FDA should use whatever discretion it enjoys to relax the "validated" requirement here.

Otherwise, w
AVXL

Your Recent History

TG
JEN
Jenoptik
LSE
NFG
Next 15
TG
PL3
TuHURA Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads